Collegium Pharmaceutical Stock Analysis

Collegium Stock Analysis Notes

About 98.0% of the company shares are held by institutions such as insurance companies. The book value of Collegium Pharmaceutical was currently reported as 7.27. The company had not issued any dividends in recent years. Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts. Collegium Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 152 people. For more info on Collegium Pharmaceutical please contact Vikram Karnani at 781 713 3699 or go to https://www.collegiumpharma.com.

Collegium Pharmaceutical Investment Alerts

Collegium Pharmaceutical Upcoming and Recent Events

Collegium Largest EPS Surprises

View All Earnings Estimates

Collegium Pharmaceutical Environmental, Social, and Governance (ESG) Scores

Collegium Stock Institutional Investors

Note, although Collegium Pharmaceutical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Collegium Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 956.54 M.

Collegium Profitablity

The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.35 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.35.

Management Efficiency

Collegium Pharmaceutical has return on total asset (ROA) of 0.0968 % which means that it generated a profit of $0.0968 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.4289 %, meaning that it created $0.4289 on every $100 dollars invested by stockholders. Collegium Pharmaceutical's management efficiency ratios could be used to measure how well Collegium Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to 0.08 this year. Return On Capital Employed is expected to rise to 0.23 this year. At this time, Collegium Pharmaceutical's Return On Assets are quite stable compared to the past year.

Technical Drivers

As of the 17th of February 2025, Collegium Pharmaceutical shows the Mean Deviation of 1.83, risk adjusted performance of (0.02), and Standard Deviation of 2.67. Collegium Pharmaceutical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Collegium Pharmaceutical standard deviation and value at risk to decide if Collegium Pharmaceutical is priced correctly, providing market reflects its regular price of 29.66 per share. Given that Collegium Pharmaceutical has information ratio of (0.04), we suggest you to validate Collegium Pharmaceutical's prevailing market performance to make sure the company can sustain itself at a future point.

Collegium Pharmaceutical Price Movement Analysis

Collegium Pharmaceutical Insider Trading Activities

Collegium Pharmaceutical Outstanding Bonds

Collegium Pharmaceutical Predictive Daily Indicators

Collegium Pharmaceutical Corporate Filings

Collegium Pharmaceutical Forecast Models

Collegium Pharmaceutical's time-series forecasting models are one of many Collegium Pharmaceutical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Collegium Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Collegium Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Collegium shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Collegium Pharmaceutical. By using and applying Collegium Stock analysis, traders can create a robust methodology for identifying Collegium entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Collegium analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Collegium analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Collegium Pharmaceutical stock analysis indicators help investors evaluate how Collegium Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Collegium Pharmaceutical shares will generate the highest return on investment. By understating and applying Collegium Pharmaceutical stock analysis, traders can identify Collegium Pharmaceutical position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collegium Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. If investors know Collegium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collegium Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Collegium Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Collegium Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collegium Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.